Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0292 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0292 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0033 | 0.112 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0012 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0229 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0033 | 0.112 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0229 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.2108 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0033 | 0.1426 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.2108 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0149 | 0.5111 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0229 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0149 | 0.5111 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0033 | 0.112 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0033 | 0.1426 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0292 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.2108 | 1 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0033 | 0.112 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0033 | 0.112 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0138 | 0.4736 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0012 | 0 | 0.5 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0292 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0138 | 0.6031 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0033 | 0.112 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0292 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.2108 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0229 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0149 | 0.6509 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0138 | 0.6031 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0033 | 0.112 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0149 | 0.5111 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0033 | 0.1426 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0149 | 0.5111 |
Onchocerca volvulus | 0.0012 | 0 | 0.5 | |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.2108 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0274 | 0.1248 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.2108 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0033 | 0.1426 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.2108 | 1 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0292 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.8184 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.1735 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.